Reassessing the risks and benefits of COVID-19 precautions in 2023
Oncotarget
.
2023 Sep 22:14:819-820.
doi: 10.18632/oncotarget.28468.
Authors
Thomas A Ollila
,
Rashida Taher
,
Prashanth Moku
PMID:
37737658
PMCID:
PMC10515730
DOI:
10.18632/oncotarget.28468
No abstract available
Keywords:
COVID; cancer; immunosuppression.
Publication types
Editorial
MeSH terms
COVID-19* / prevention & control
Humans
Risk Assessment